Obesity, inflammation, and insulin resistance

Harvard University, Cambridge, Massachusetts, United States
Gastroenterology (Impact Factor: 13.93). 06/2007; 132(6):2169-80. DOI: 10.1053/j.gastro.2007.03.059
Source: PubMed

ABSTRACT Weight gain and obesity are major risk factors for conditions and diseases ranging from insulin resistance and type 2 diabetes mellitus to atherosclerosis and the sequelae of nonalcoholic fatty liver disease. A chronic, subacute state of inflammation often accompanies the accumulation of excess lipid in adipose tissue and liver (hepatic steatosis), evidenced by changes in both inflammatory cells and biochemical markers of inflammation. These changes can be seen in the involved tissues and systemically, in terms of elevated circulating levels of inflammatory markers. The link between obesity and inflammation has therefore raised the important question of whether obesity-induced inflammation plays a pathogenic role in the development and progression of these disorders. We review the rapidly expanding body of animal and clinical data that support potential roles for inflammation in the pathogenesis of insulin resistance and type 2 diabetes mellitus.

Download full-text


Available from: Laura Herrero, Jan 23, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to assess the effects of chronic free fatty acid (FFA) exposure on gene expression and the functional state of human pancreatic islets. Chronic exposure of islets to oleate (OA) resulted in a significant reduction in glucose-stimulated insulin secretion (GSIS) compared with control (466+/-82 vs 234+/-57 ng/microg DNA, P<0.05). OA treatment also led to reduction in total insulin content of the islets (17 609+/-3816 vs 10 599+/-3876 ng insulin/microg DNA) and to an increase in the rate of reactive oxygen species (ROS) generation. Interestingly, the suppressive effects of OA on biosynthesis and secretion of insulin were accompanied by alteration in the expression of 40 genes, as determined by microarray analysis and subsequent qPCR validation. The majority of genes regulated by OA encoded metabolic enzymes. The expression of enzymes involved in oxidative defense was elevated, indicating a link between ROS generation and antioxidant defense activation. Additionally, pretreatment of human islets with OA led to a significant increase (30%) in the rate of oxidation of this fatty acid and to a significant decrease (75%) in glucose oxidation. Importantly, individual analysis of gene clusters from the islets of all donors revealed the induction of genes involved in inflammation and immunity, which provides further evidence that FFA are risk factors for the development of type 2 diabetes. In summary, our data indicate that chronic exposure of human islets to FFA activates inflammatory and metabolic pathways that lead to oxidative stress, reduced beta-cell insulin content, and inhibition of GSIS.
    Journal of Endocrinology 03/2008; 196(3):455-64. DOI:10.1677/JOE-07-0174 · 3.59 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent study reveals that obesity and its related disorders occupying major share in the spectrum of health, disease and management. It is one of the disorders of non-communicable disease, which laid down foundation stone of diabetes mellitus, metabolic syndrome, hypertension and others. The etio-pathogenesis, management and consequences of obesity are not very clear and it still evolving in biomedical sciences. As a disease entity it is multi-factoral metabolic disorders, is very near to Medoroga/ Sthaulya of Ayurveda. Charaka has described obesity as a disease of the fat tissue (Medoroga) leading to hugeness (sthoulyam). The prevalence of obesity is higher in urban areas than in rural populations of India, due to a steady erosion of the holistic way of life in the cities as well as the sedentary and overeating habit. The spiritual, psychological, and physical levels of human health and disease is given due importance in Ayurveda. The current understanding of adipose tissue as an endocrine organ coupled with the successful leads from Ayurveda may form a scientific basis for the management of obesity. Already, Commiphora wightii (Guggulu) is emerging as a drug of global potential for obesity and hyperlipidemia. Therefore, Ayurveda inspired line of prevention and management provides a great success in obese patients. 1.1. Introduction: In the era of urbanisation, obesity has emerged as a serious health issue of both developed and developing nations and recognised as serious public health problems of the 21st century. It recognized as one of the important lifestyle and metabolic disorders. It is a leading preventable cause of death world over. The incidence of obesity has been felt most dramatically in urban areas and gradually acquires its place in semi-urban and rural areas. WHO has predicted in 1997 that overweight and obesity may soon replace under nutrition and infectious diseases as the most significant cause of poor health. In 2005 WHO estimates that, at least 400 million adults (9.8%) are obese at world map, with higher rates among women than men. Obesity is the main reason for about 80% of type 2 diabetes, about 70% of cardiovascular diseases, and 42% of breast and colon cancers. At present childhood-obesity is also running out of control. In the past two decades, the number of overweight children and adolescents has doubled. Around
    Integrative Approach to Metabolic Disorders (IAMD), 1st edited by Chief Editor Ratnesh Kumar Rao Executive Editor Dr. K.R.C. Reddy Editor Dr. Neeru Nathani, 01/2014: chapter CONCEPTUAL BACKGROUND OF OBESITY (STHAULYA/MEDO ROGA) & AN APPROACH FOR ITS MANAGEMENT THROUGH AYURVEDA: pages 47- 60; MRFSW., ISBN: ISBN No. 978-81-926935-0-7 (Year – 2013-2014)
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The direction of the association between mental health and adiposity is poorly understood. Our objective was to empirically examine this link in a UK study. This is a prospective cohort study of 3 388 people (men) aged ≥ 18 years at study induction who participated in both the UK Health and Lifestyle Survey at baseline (HALS-1, 1984/1985) and the re-survey (HALS-2, 1991/1992). At both survey examinations, body mass index, waist circumference and self-reported common mental disorder (the 30-item General Health Questionnaire, GHQ) were measured. Logistic regression models were used to compute odds ratios (OR) and accompanying 95% confidence intervals (CI) for the associations between (1) baseline common mental disorder (QHQ score > 4) and subsequent general and abdominal obesity and (2) baseline general and abdominal obesity and re-survey common mental disorders. After controlling for a range of covariates, participants with common mental disorder at baseline experienced greater odds of subsequently becoming overweight (women, OR: 1.30, 1.03 - 1.64; men, 1.05, 0.81 - 1.38) and obese (women, 1.26, 0.82 - 1.94; men, OR: 2.10, 1.23 - 3.55) than those who were free of common mental disorder. Similarly, having baseline common mental health disorder was also related to a greater risk of developing moderate (1.57, 1.21 - 2.04) and severe (1.48, 1.09 - 2.01) abdominal obesity (women only). Baseline general or abdominal obesity was not associated with the risk of future common mental disorder. These findings of the present study suggest that the direction of association between common mental disorders and adiposity is from common mental disorder to increased future risk of adiposity as opposed to the converse.
    PLoS ONE 05/2015; 10(5):e0119970. DOI:10.1371/journal.pone.0119970 · 3.53 Impact Factor